Q-Vant Biosciences collaborates with Tulane University to develop a promising new oral vaccine adjuvant
Q-Vant Biosciences Inc., a biosciences company specialized in manufacturing and formulating open-access saponin-based adjuvants from...
Read more
Articles Posted byMatthieu Privat
Q-VANT and SPI Pharma offering broader access to sustainable and scalable pharma-grade saponin adjuvants
SPI Pharma, Inc. and Q-Vant Biosciences, Inc. announce a strategic partnership which includes an investment to expand Q-Vant’s...
Read more
Recent Comments